Inventor · disambiguated record
Andreas Pahl
Also filed as: PAHL ANDREAS
6 granted patents·11 pending applications·8 citations·filing 2012–2024
72Inventor score
Files withHEIDELBERG PHARMA RES GMBH11TAKEDA GMBH2FLOCKERZI DIETER1HEIDELBERG PHARMA GMBH1STENGEL THOMAS1
Top patents by PatentIndex Score
17 records- 0186US10842882B2Amatoxin-antibody conjugatesHEIDELBERG PHARMA GMBH·Filed 2016·Granted Nov 24, 2020·5 cites·9 claims
- 0280US11583569B2PSMA-targeting amanitin conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2018·Granted Feb 21, 2023·2 cites·18 claims
- 0375US2025064960A1B-lymphocyte specific amatoxin antibody conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2024·Application pending·0 cites
- 0472US2025009901A1Composition comprising a combination of immune checkpoint inhibitor and antibody-amatoxin conjugate for use in cancer therapyHEIDELBERG PHARMA RES GMBH·Filed 2024·Application pending·0 cites
- 0571US12403201B2B-lymphocyte specific amatoxin antibody conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2022·Granted Sep 2, 2025·0 cites·8 claims
- 0668US11446388B2Amanitin antibody conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2017·Granted Sep 20, 2022·1 cites·3 claims
- 0763US2024307549A1Subcutaneously administered antibody-drug conjugates for use in cancer treatmentHEIDELBERG PHARMA RES GMBH·Filed 2024·Application pending·0 cites
- 0862US2024165257A1Anti-gucy2c antibody and uses thereofHEIDELBERG PHARMA RES GMBH·Filed 2023·Application pending·0 cites
- 0961US2022133902A1Composition Comprising a Combination of Immune Checkpoint Inhibitor and Antibody-Amatoxin Conjugate for Use in Cancer TherapyHEIDELBERG PHARMA RES GMBH·Filed 2021·Application pending·0 cites
- 1060US2023355792A1Methods of improving the therapeutic indexHEIDELBERG PHARMA RES GMBH·Filed 2023·Application pending·0 cites
- 1152US2024082416A1Amatoxin analogs and uses thereofUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 1251US11976131B2Humanized antibodies against PSMAHEIDELBERG PHARMA RES GMBH·Filed 2019·Granted May 7, 2024·0 cites·20 claims
- 1348US2025195678A1B-lymphocyte specific amatoxin antibody conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2020·Application pending·0 cites
- 1438US2016108049A1Novel Phthalazinone-Pyrrolopyrimidinecarboxamide DerivativesTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 1536US2014112945A1Novel phthalazinone-pyrrolopyrimidinecarboxamide derivativesSTENGEL THOMAS·Filed 2012·Application pending·0 cites
- 1634US2014113877A1Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] isoquinoline compoundsFLOCKERZI DIETER·Filed 2012·Application pending·0 cites
- 1732US9309187B2EP2 receptor agonistsTAKEDA GMBH·Filed 2013·Granted Apr 12, 2016·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Andreas Pahl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →